PRESS-RELEASE ·Filed Apr 2, 2026
Press release · Announcement
Actionable Insight • Neutral
No trading catalyst is present in this release. Traders should monitor the upcoming presentations for any unexpected updates on clinical data, development timelines, or funding plans.
Final — all horizons settled through T+60d
CATX ▼ -22.68% at T+60d
NEUTRAL call -22.68% · α vs SPY -36.84% · entry $4.41 → $3.41
T+1d
-0.68%
call -0.68% · α -1.16%
$4.38
settled 7mo ago
T+5d
+1.36%
call +1.36% · α -2.26%
$4.47
settled 7mo ago
T+20d
-11.56%
call -11.56% · α -21.44%
$3.90
settled 6mo ago
T+60d
-22.68%
call -22.68% · α -36.84%
$3.41
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Perspective Therapeutics announced upcoming investor presentations at two biopharma conferences in mid-April 2026. The filing is a routine disclosure of management participation in industry events and contains no new financial or clinical data.
Key Facts
- Company to present at Needham Virtual Healthcare Conference on April 14, 2026 (9:30-10:10 a.m. ET)
- Participating in one-on-one meetings at Piper Sandler Spring Biopharma Symposium on April 16, 2026 in Boston
- No new clinical, financial, or operational updates provided
- Press release consists solely of forward-looking statements and corporate event logistics
Financial Impact
No immediate financial impact
Risk Factors
- Forward-looking statements are subject to significant risks including clinical trial delays, funding shortfalls, and regulatory setbacks
- Lack of near-term catalysts may contribute to stock volatility ahead of conference appearances
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3267215 |
24 reports for CATX
33% Hit rate @ T+20 Went positive at some point 3 of 4 best @ T+60▲ +5.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $2.28 | awaiting T+20 | — | $1.25 (−44.96%) |
Oct 8, 2026 18d ago | 8-K | $2.71 | awaiting T+20 | — | $1.25 (−53.69%) |
Oct 2, 2026 24d ago | Press Release | $2.76 | awaiting T+20 | — | $1.25 (−54.53%) |
Sep 14, 2026 6w ago | 8-K | $2.92 $2.52 | ▼ −13.70% | ▼ −15.96% | $1.25 (−57.02%) |
Sep 11, 2026 6w ago | Press Release | $2.81 $2.66 | ▼ −5.34% | ▼ −7.21% | $1.25 (−55.34%) |
Sep 8, 2026 6w ago | Insider Cluster | $2.99 $2.46 | ▼ −17.73% | ▼ −19.67% | $1.25 (−58.03%) |
Sep 4, 2026 7w ago | Insider Cluster | $3.12 $2.36 | ▼ −24.36% | ▼ −26.07% | $1.25 (−59.78%) |
Sep 4, 2026 7w ago | Insider Cluster | $3.12 $2.36 | ▼ −24.36% | ▼ −26.07% | $1.25 (−59.78%) |
Aug 10, 2026 10w ago | 8-K | $3.18 $2.99 | ▼ −5.97% | ▼ −4.92% | $1.25 (−60.53%) |
Jul 17, 2026 14w ago | Press Release | $2.99 $3.20 | ▲ +7.02% | ▲ +2.58% | $1.25 (−58.03%) |
Showing 10 of 24
US Market Status
Market Open — Closes in 3h 23m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers